---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-121725"
form_type: "8-K"
ticker: "LAB"
cik: "0001162194"
company_name: "STANDARD BIOTOOLS INC."
filed_at: "2023-11-29T23:59:59+00:00"
generated_at: "2026-06-07T20:13:12.829493+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "medium"
source: SEC EDGAR
---

# Standard BioTools and SomaLogic issue updated joint investor presentation for planned merger

## Summary
- Updated investor presentation released Nov 28, 2023 outlines combined company strategy and financial outlook.
- Merger announced Oct 4, 2023; expected to create a diversified life sciences tools leader with broader product suite.
- Presentation includes non-binding forward-looking projections on cost synergies and revenue opportunities.
- Stockholders of both companies will vote on the transaction; regulatory approvals still required.

## SEC filing metadata
- accession: 0001104659-23-121725
- form_type: 8-K
- ticker: LAB
- cik: 0001162194
- company_name: STANDARD BIOTOOLS INC.
- filed_at: 2023-11-29T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1162194/000110465923121725/0001104659-23-121725-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1162194/000110465923121725/tm2331700d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-121725
- JSON: https://secwatch.observer/filing/0001104659-23-121725.json
- Plain text: https://secwatch.observer/filing/0001104659-23-121725.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.